ADAPTHEALTH ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS, RAISES FULL-YEAR 2021 GUIDANCE, AND PROVIDES FULL-YEAR 2022 GUIDANCE Plymouth Meeting, PA

ADAPTHEALTH ANNOUNCES THIRD QUARTER 2021

RAISES FULL-YEAR 2021 GUIDANCE, AND PROVIDES FULL-YEAR 2022 GUIDANCE

Plymouth Meeting, PA - November 4, 2021 - AdaptHealth

Corp. (NASDAQ: AHCO) ("AdaptHealth" or "the Company"), a national leader in providing patient-centered, healthcare-at-home

solutions including home medical equipment, medical supplies, and related services, announced today

financial results for the third quarter ended September 30, 2021.

Third Quarter Results

Guidance Increased for 2021

Based on current business, market trends, and acquisitions completed

to date, the Company is increasing its previously issued financial guidance for fiscal year 2021 as follows:

Guidance Established for 2022

The Company is also establishing initial financial guidance for fiscal

year 2022 as follows:

Guidance for 2021 and 2022 does not include any contribution from acquisitions

that have not yet closed. 2022 also excludes any potential impact from continuing sequestration relief, continuing PHE benefits, and any change to the DMEPOS fee

Management Commentary

Steve Griggs, Chief Executive Officer, commented, "We are very

pleased with our operating and financial performance for the quarter, which reflected the outstanding efforts of our team members. We

continue to drive organic growth in the face of challenging external circumstances (including the ongoing impact of the Philips recall),

as well as further expanding our presence through strategic acquisitions in key markets. During the third quarter, we completed six acquisitions

and today we are announcing another four deals in the HME and diabetes product lines."

Mr. Griggs continued, "Having already achieved many of the targets

we set for the AeroCare merger, we are focused as a combined company on a strong finish to the year and continuing to execute on our core

strategies of organic growth, improving operations, and closing accretive acquisitions."

Josh Parnes, President, commented, "We continue to leverage technology

to drive operational improvements, such as our patient-facing technology. The Company continues to progress in evolving our business toward

chronic disease management, with an overall goal to drive improvements in patient outcomes and reductions in the cost of care, while at

the same time continuing to deliver strong organic growth from our existing businesses."

Management will host a conference at 8:30 am ET

today to discuss the results and business activities. Interested parties may participate in the call by dialing:

Webcast registration: Click Here

Following the live call, a replay will be available for six months

on the Company's website, www.adapthealth.com under "Investor Relations."

About AdaptHealth Corp.

AdaptHealth is a national leader in

providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services.

The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home,

adapt to challenges in their activities of daily living, and thrive. Product and service offerings include (i) sleep therapy

equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep

apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and

insulin pumps), (iii) home medical equipment (HME) to patients discharged from acute care and other facilities, (iv) oxygen and

related chronic therapy services in the home, and (v) other HME devices and supplies to chronically ill patients with wound care,

urological, incontinence, ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly

diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and

clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching approximately 3.5

million patients annually in all 50 states through its network of 716 locations in 47 states.

Forward-Looking Statements

This press release includes certain statements that are not historical

facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation

Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will,"

"estimate," "continue," "anticipate," "intend," "expect," "should,"

"would," "plan," "predict," "potential," "seem," "seek," "future,"

"outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical

matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of

revenue and other financial and performance metrics and projections of market opportunity and expectations and the Company's acquisition

pipeline. These statements are based on various assumptions and on the current expectations of AdaptHealth management and are not predictions

of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as,

and must not be relied on, by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability.

Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances

are beyond the control of the Company.

These forward-looking statements are subject to a number of risks and

uncertainties, including the outcome of judicial and administrative proceedings to which the Company may become a party or governmental

investigations to which the Company may become subject that could interrupt or limit the Company's operations, result in adverse

judgments, settlements or fines and create negative publicity; changes in the Company's clients' preferences, prospects and

the competitive conditions prevailing in the healthcare sector; and the impact of the recent coronavirus (COVID-19) pandemic and the Company's

response to it. A further description of such risks and uncertainties can be found in the Company's filings with the Securities

and Exchange Commission. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results

implied by these forward-looking statements. There may be additional risks that the Company presently knows or that the Company currently

believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition,

forward-looking statements reflect the Company's expectations, plans or forecasts of future events and views as of the date of this

press release. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. However,

while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims

any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's assessments as

of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Use of Non-GAAP Financial Information and Financial Guidance

This release contains non-GAAP financial guidance, which is adjusted

to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis. These non-GAAP

items are adjusted after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics,

such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative

of future operating results. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods.

The Company uses EBITDA, Adjusted EBITDA and Adjusted EBITDA less Patient

Equipment Capex, which are financial measures that are not prepared in accordance with generally accepted accounting principles in the

United States, or U.S. GAAP, to analyze its financial results and believes that they are useful to investors, as a supplement to U.S.

GAAP measures. In addition, the Company's ability to incur additional indebtedness and make investments under its existing credit

agreement is governed, in part, by its ability to satisfy tests based on a variation of Adjusted EBITDA less Patient Equipment Capex.

The Company believes Adjusted EBITDA less Patient Equipment Capex is

useful to investors in evaluating the Company's financial performance. The Company's business requires significant investment

in equipment purchases to maintain its patient equipment inventory. Some equipment title transfers to patients' ownership after

a prescribed number of fixed monthly payments. Equipment that does not transfer wears out or often times is not recovered after a patient's

use of the equipment terminates. The Company uses this metric as the profitability measure in its incentive compensation plans that have

a profitability component and to evaluate acquisition opportunities, where it is most often used for purposes of contingent consideration

arrangements. In addition, the Company's debt agreements contain covenants that use a variation of Adjusted EBITDA less Patient

Equipment Capex for purposes of determining debt covenant compliance. For purposes of this metric, patient equipment capital expenditure

is measured as the value of the patient equipment received during the accounting period without regard to whether the equipment is purchased

or financed through lease transactions.